J&J cutting back on stents, expects $500M charge
NEW YORK - June 15, 2011 (WPVI) -- Johnson & Johnson will cut back on manufacturing and development of heart stents, and will take a charge of $500 million to $600 million as it restructures its Cordis heart device business.
The New Brunswick, N.J., company says Cordis will stop making Cypher and Cypher Select drug-coated stents by year-end, and it will also stop development of a new drug-coated stent called Nevo. Cordis will focus on other areas of the heart device market where there is greater demand.
The company will eliminate up to 1,000 jobs as it shuts two manufacturing plants and consolidates a research and development team.
Stents are mesh-wire tubes that are used to hold arteries open after they are surgically cleared of fatty plaque. Sales have been hurt in recent years by safety concerns.
new york, new jersey, johnson & johnson, business/finance
- Police: Missing boy struck by car
- Temps soar above normal 33 min ago
- WATCH: Action News Online
- 2013 Troop Greetings
- Coffins unearthed at North Philly school 52 min ago
- No cheer uniforms for North Philadelphia Aztec squad 40 min ago
- Attack in Center City caught on camera
- Police: Threat to father used in phone scam
- Stolen cobalt-60 found abandoned in Mexico 55 min ago
- Report: NSA tracks billions of cellphones daily
- Kutztown coach accused of covering up teen's rape
- Prosecutor: Sex investigation of FSU QB over
- Photos: 6abc at Q102 Jingle Ball 2013
- Video: 20th annual Phila. holiday tree lighting 49 min ago
- 20th annual Phila. holiday tree lighting
49 min ago
- Firefighters battle Hunting Park blaze
44 min ago
- Coffins unearthed at North Philly school
52 min ago